Drug Eluting Stents Market Size, Share, Growth, Outlook, Opportunity Analysis & forecast 2019 - 2027

                                                                               
A drug-eluting stent (DES) is a peripheral or coronary stent that gently releases a medication to prevent cell proliferation in constricted, sick peripheral or coronary arteries.

         Drug Eluting Stents Market


A drug-eluting stent (DES) is a peripheral or coronary stent that gently releases a medication to prevent cell proliferation in constricted, sick peripheral or coronary arteries. Drug-eluting stents have a coating of medication that is released (eluted) to prevent scar tissue formation in artery walls. Eluted medication keeps arteries smooth and exposed, allowing for proper blood flow and lowering the risk of restenosis. The DES procedure is considered the gold standard for the treatment of coronary heart disease because it has several advantages, including improved vessel repair, minimum invasiveness, and the elimination of the requirement for long-term dual antiplatelet therapy. Certain drugs or pharmacological therapy are indicated for patients having DES implants.

The Drug Eluting Stents Market is primarily driven by the growing senior population, which is at a higher risk of developing arterial diseases. Furthermore, bad eating habits, sedentary lifestyles, and a lack of exercise raise the prevalence of atherosclerosis globally, propelling market expansion. Furthermore, the drug eluting stent market is expected to develop because to an increase in product approvals and minimally invasive approaches for DES placement. Furthermore, an increase in the prevalence of numerous cardiovascular illnesses, such as abnormal heart rhythms, heart attacks, heart valve disease, congenital heart disorders, and heart failure function, is predicted to drive market growth. However, the market's expansion is limited by government restrictions governing product approval. During the forecast period, however, the rise in potential in emerging economies is expected to generate attractive chances for market expansion.


Market Segmentation:

By Application
  • Coronary Artery Disease
  • Peripheral Artery Disease

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The key players operating in the global drug eluting stents market include Boston Scientific Corporation, Medtronic, Plc, Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys, Abbott Vascular Inc., AlviMedica Medical Technologies Inc., Amaranth Medical, Inc., HangZhou HuaAn Biotechnology Co., Ltd, XTENT, Inc., Cardionovum GmbH, Cordis Corporation, and Kyoto Medical Planning Co., Ltd.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Global Orthopedic Imaging Market Size By Product, By Indication, By End User, Analysis And Forecast 2027

Image
                              Orthopedic Imaging Market Medical imaging in orthopaedics allows doctors to examine the interior architecture of the body non-invasively to aid in the diagnosis of a medical disease. Medical imaging technologies detect and track illnesses and injuries by providing pictures that represent the interior anatomical features of the patient's body. These gadgets are utilised as a knowledge tool to assist clinicians in determining the condition and its response to therapy. Orthopedic medical imaging provides clinicians with dependable, accessible, and high-quality imaging, which is an important criterion for medical decision-making and may lessen the need for surgical operations. Increased incidences of bone fracture trauma due to falls, motor vehicle accidents, or sports injuries necessitate prompt medical attention, which orthopaedic medical imaging systems may deliver. According to the ...
Read more